Search alternatives:
nn decrease » _ decrease (Expand Search), gy decreased (Expand Search), b1 decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
e decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
nn decrease » _ decrease (Expand Search), gy decreased (Expand Search), b1 decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
e decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
-
17221
-
17222
Mechanisms of Cellulose Fiber Comminution to Nanocellulose by Hyper Inertia Flows
Published 2022“…Refinement of these nanocelluloses to fibrils is then achieved by an increase in critical bending events, i.e., decreasing the turbulent length scale and increasing the residence time of fibrils in the turbulent flow.…”
-
17223
Mechanisms of Cellulose Fiber Comminution to Nanocellulose by Hyper Inertia Flows
Published 2022“…Refinement of these nanocelluloses to fibrils is then achieved by an increase in critical bending events, i.e., decreasing the turbulent length scale and increasing the residence time of fibrils in the turbulent flow.…”
-
17224
Mechanisms of Cellulose Fiber Comminution to Nanocellulose by Hyper Inertia Flows
Published 2022“…Refinement of these nanocelluloses to fibrils is then achieved by an increase in critical bending events, i.e., decreasing the turbulent length scale and increasing the residence time of fibrils in the turbulent flow.…”
-
17225
-
17226
<i>par2b</i> is partially required downstream of <i>ap1b1a</i> for aggregate formation and increased <i>mmp9</i> expression in the epidermis.
Published 2023“…Compared to the strong <i>mmp9</i> expression observed in 100% of the <i>atp1b1a</i> single mutant embryos, 30% of <i>atp1b1a</i> mutants heterozygous for <i>par2b</i> showed a decreased <i>mmp9</i> expression. …”
-
17227
Flow chart of study selection.
Published 2023“…<div><p>Background</p><p>This systematic review and network meta-analysis (NMA) aimed to compare the efficacy of all available treatments for severe melioidosis in decreasing hospital mortality and to identify eradication therapies with low disease recurrence rates and minimal risk of adverse drug events (AEs).…”
-
17228
-
17229
DataSheet_2_Impact of microvessel patterns and immune status in NSCLC: a non-angiogenic vasculature is an independent negative prognostic factor in lung adenocarcinoma.pdf
Published 2023“…In multivariate analyses, LUAD NAA+ pattern was a significant independent prognostic factor; HR 2.37 (CI 95%, 1.50-3.73, p< 0.001). …”
-
17230
-
17231
Antibodies used for flow cytometry experiments.
Published 2023“…RA was devoid of serious side effects, and within 24 hours from the start of infusion was associated with increased oxygen saturation (93.8 ± 0.58 vs 96.6 ± 1.08%, P<0.05), decreased D-dimer (754 ± 17 vs 518 ± 98 ng/ml, P<0.05), and a trend toward decreased CRP (3.80 ± 1.40 vs 1.98 ± 0.74 mg/dL, P = 0.075). …”
-
17232
Subject flow diagram.
Published 2023“…RA was devoid of serious side effects, and within 24 hours from the start of infusion was associated with increased oxygen saturation (93.8 ± 0.58 vs 96.6 ± 1.08%, P<0.05), decreased D-dimer (754 ± 17 vs 518 ± 98 ng/ml, P<0.05), and a trend toward decreased CRP (3.80 ± 1.40 vs 1.98 ± 0.74 mg/dL, P = 0.075). …”
-
17233
-
17234
-
17235
-
17236
-
17237
Suppression of FcγRIa expression using shRNA prevents <i>E. coli</i> K1 entry into RAW 264.7 cells.
Published 2010“…(C and D) Total cell bound and intracellular bacteria (measured by gentamicin protection assay) were determined after infecting FcγRIa<sup>−</sup>/− and CR3<sup>−</sup>/RAW cells with <i>E. coli</i> K1 or Group B <i>streptococcus. E. coli</i> K1 or GBS that were bound or intracellular in control cells were taken as 100%. …”
-
17238
Inhibition of the Wnt pathway by SFRP2 reduced mCSCs’ resistance to H<sub>2</sub>O<sub>2</sub>-induced apoptosis.
Published 2013“…<p>(A) Total mRNA was isolated from mCSCs treated with a range of concentrations of the SFRP2 protein (0, 3, 10, 15, 20, 50, 100 and 150 nM) for 24 h in serum-free medium. …”
-
17239
-
17240